Dr. john Smith, PharmD, BCPS

Pharmacological Mechanisms and the Evidence for Sleep Initiation Treatment

Insomnia disorder, defined by persistent difficulty falling asleep, staying asleep, or experiencing restorative sleep despite adequate opportunity, with consequent daytime impairment, affects approximately ten percent of adults as a chronic condition and a substantially larger proportion episodically. The impact of chronic insomnia on health, functioning, and quality of life is pervasive, with impairments in cognitive […]

Read More

Obesity Management: Evidence-Based Pharmacotherapy for Weight Loss

Obesity is a chronic, multifactorial disease associated with a spectrum of serious comorbidities including type 2 diabetes, cardiovascular disease, hypertension, obstructive sleep apnea, certain cancers, and osteoarthritis. Despite its disease status and its enormous public health impact, obesity remains undertreated, with many patients receiving counseling alone without access to the full range of evidence based […]

Read More

Generalized Anxiety Disorder: Understanding Pathophysiology

Generalized anxiety disorder is one of the most prevalent psychiatric conditions globally and one of the most commonly encountered in primary care settings, yet it remains underdiagnosed and undertreated in a significant proportion of affected individuals. The disorder is characterized by persistent, excessive worry about multiple domains of everyday life that is difficult to control […]

Read More

Muscle Spasms: Clinical Applications and Management of a Centrally Acting Relaxant

Muscle spasms are among the most common and painful musculoskeletal complaints encountered in clinical practice. Whether arising from acute injury, overuse, poor posture, or underlying neurological conditions, involuntary muscle contractions produce severe localized pain, restrict movement, and can significantly disrupt sleep and daily activities. The management of acute muscle spasms encompasses rest, heat and cold […]

Read More

The Management of Narcolepsy: Restoring Wakefulness in a Neurological Sleep Disorder

Narcolepsy is a chronic neurological disorder that profoundly disrupts the brain’s ability to regulate sleep wake transitions, leading to excessive and often irresistible daytime sleepiness that cannot be corrected through adequate nighttime sleep alone. The consequences extend far beyond simple fatigue, encompassing safety risks, occupational impairment, social difficulties, and a pervasive loss of autonomy. Stimulant […]

Read More

Sildenafil in Pulmonary Arterial Hypertension

Pulmonary arterial hypertension is a severe, progressive disease of the pulmonary vasculature characterized by abnormally elevated pressure in the pulmonary arteries, which ultimately leads to right ventricular failure and death if untreated. For decades, treatment options for this condition were limited, and the prognosis was grim. The discovery that sildenafil, the active ingredient in Viagra, […]

Read More

Panic Disorder and the Clinical Role of Xanax: Rapid Intervention in a Debilitating Condition

Panic disorder is a psychiatric condition defined by the recurrence of unexpected, intense episodes of fear that reach a peak within minutes and are accompanied by a constellation of physical and psychological symptoms. These panic attacks generate such profound distress that many individuals develop anticipatory anxiety between episodes and begin avoiding situations they associate with […]

Read More

Stimulants, Caffeine, and Panic Attacks: How Substances Trigger Anxiety Episodes

How Stimulants Trigger Panic Attacks: The Pharmacological Mechanism Stimulant substances, ranging from the ubiquitous caffeine in coffee and energy drinks to prescription medications and recreational drugs, share a common capacity to activate the sympathetic nervous system and trigger anxiety and panic attacks in susceptible individuals. Understanding how stimulants interfere with anxiety regulation clarifies why limiting […]

Read More